173 related articles for article (PubMed ID: 22194848)
1. The discovery of putative urine markers for the specific detection of prostate tumor by integrative mining of public genomic profiles.
Chen M; Wang K; Zhang L; Li C; Yang Y
PLoS One; 2011; 6(12):e28552. PubMed ID: 22194848
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatic analysis of dysregulated proteins in prostate cancer patients reveals putative urinary biomarkers and key biological pathways.
Lima T; Henrique R; Vitorino R; Fardilha M
Med Oncol; 2021 Jan; 38(1):9. PubMed ID: 33452612
[TBL] [Abstract][Full Text] [Related]
3. Integration of Automatic Text Mining and Genomic and Proteomic Analysis to Unravel Prostate Cancer Biomarkers.
Lima T; Ferreira R; Freitas M; Henrique R; Vitorino R; Fardilha M
J Proteome Res; 2022 Feb; 21(2):447-458. PubMed ID: 35114790
[TBL] [Abstract][Full Text] [Related]
4. Urinary biomarkers of prostate cancer.
Fujita K; Nonomura N
Int J Urol; 2018 Sep; 25(9):770-779. PubMed ID: 30129068
[TBL] [Abstract][Full Text] [Related]
5. Detection of miRNAs in urine of prostate cancer patients.
Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer invasion and metastasis: insights from mining genomic data.
Hudson BD; Kulp KS; Loots GG
Brief Funct Genomics; 2013 Sep; 12(5):397-410. PubMed ID: 23878130
[TBL] [Abstract][Full Text] [Related]
7. The present and future of prostate cancer urine biomarkers.
Rigau M; Olivan M; Garcia M; Sequeiros T; Montes M; Colás E; Llauradó M; Planas J; Torres Id; Morote J; Cooper C; Reventós J; Clark J; Doll A
Int J Mol Sci; 2013 Jun; 14(6):12620-49. PubMed ID: 23774836
[TBL] [Abstract][Full Text] [Related]
8. Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer.
Duijvesz D; Versluis CY; van der Fels CA; Vredenbregt-van den Berg MS; Leivo J; Peltola MT; Bangma CH; Pettersson KS; Jenster G
Int J Cancer; 2015 Dec; 137(12):2869-78. PubMed ID: 26139298
[TBL] [Abstract][Full Text] [Related]
9. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.
Yang Y; Pospisil P; Iyer LK; Adelstein SJ; Kassis AI
PLoS One; 2008; 3(11):e3661. PubMed ID: 18987750
[TBL] [Abstract][Full Text] [Related]
10. Urinary Biomarkers for Prostate Cancer.
Giunchi F; Ciccarese C; Montironi R; Scarpelli M; Lopez-Beltran A; Cheng L; Moch H; Massari F; Fiorentino M
Curr Drug Metab; 2017 Oct; 18(8):723-726. PubMed ID: 28524004
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes.
Hendriks RJ; Dijkstra S; Jannink SA; Steffens MG; van Oort IM; Mulders PF; Schalken JA
Clin Chem Lab Med; 2016 Mar; 54(3):483-92. PubMed ID: 26630694
[TBL] [Abstract][Full Text] [Related]
12. Construction and analysis of protein-protein interaction networks based on proteomics data of prostate cancer.
Chen C; Shen H; Zhang LG; Liu J; Cao XG; Yao AL; Kang SS; Gao WX; Han H; Cao FH; Li ZG
Int J Mol Med; 2016 Jun; 37(6):1576-86. PubMed ID: 27121963
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer.
Nilsson J; Skog J; Nordstrand A; Baranov V; Mincheva-Nilsson L; Breakefield XO; Widmark A
Br J Cancer; 2009 May; 100(10):1603-7. PubMed ID: 19401683
[TBL] [Abstract][Full Text] [Related]
14. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.
McKiernan J; Donovan MJ; O'Neill V; Bentink S; Noerholm M; Belzer S; Skog J; Kattan MW; Partin A; Andriole G; Brown G; Wei JT; Thompson IM; Carroll P
JAMA Oncol; 2016 Jul; 2(7):882-9. PubMed ID: 27032035
[TBL] [Abstract][Full Text] [Related]
15. Using gene expression from urine sediment to diagnose prostate cancer: development of a new multiplex mRNA urine test and validation of current biomarkers.
Mengual L; Lozano JJ; Ingelmo-Torres M; Izquierdo L; Musquera M; Ribal MJ; Alcaraz A
BMC Cancer; 2016 Feb; 16():76. PubMed ID: 26856686
[TBL] [Abstract][Full Text] [Related]
16. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.
Foj L; Ferrer F; Serra M; Arévalo A; Gavagnach M; Giménez N; Filella X
Prostate; 2017 May; 77(6):573-583. PubMed ID: 27990656
[TBL] [Abstract][Full Text] [Related]
17. In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer.
Baruah MM; Sharma N
Med Oncol; 2019 Apr; 36(5):43. PubMed ID: 30937635
[TBL] [Abstract][Full Text] [Related]
18. [Update on the diagnosis of PCa in urine. The current role of urine markers].
Fernandez-Serra A; Casanova-Salas I; Rubio L; Calatrava A; García-Flores M; García-Casado Z; López-Guerrero JA; Rubio-Briones J
Arch Esp Urol; 2015 Apr; 68(3):240-9. PubMed ID: 25948797
[TBL] [Abstract][Full Text] [Related]
19. Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery.
Lee B; Mahmud I; Marchica J; Dereziński P; Qi F; Wang F; Joshi P; Valerio F; Rivera I; Patel V; Pavlovich CP; Garrett TJ; Schroth GP; Sun Y; Perera RJ
Sci Rep; 2020 Feb; 10(1):3716. PubMed ID: 32111915
[TBL] [Abstract][Full Text] [Related]
20. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.
Stephan C; Jung M; Rabenhorst S; Kilic E; Jung K
Clin Chem Lab Med; 2015 Jun; 53(7):1109-18. PubMed ID: 25720086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
